🔎 Trials Near Me

Dachaigh › Leukemia myeloid geur › Florida › Tampa

Sgrùdaidhean clionaigeach Leukemia myeloid geur ann an Tampa, FL

Tha 29 sgrùdaidhean airson Leukemia myeloid geur a’ lorg phàirtichean aig làraichean ann agus timcheall air Tampa (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

A’ fastadhÌre 2
  • Moffitt Cancer Center-International Plaza, Tampa
  • Moffitt Cancer Center - McKinley Campus, Tampa
  • Moffitt Cancer Center, Tampa
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT05564390

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
  • Saint Joseph's Hospital/Children's Hospital-Tampa, Tampa
Aoisean 40 gu 75 · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT05334069

A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

A’ fastadhÌre 1
  • Moffitt Cancer Center, Tampa
Aoisean 12 gu 78 · Gach gnè · Air ùrachadh 29 Sult 2026 · NCT03802695

A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)

A’ fastadhÌre 3
  • Moffit Cancer center, Tampa
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06852222

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

A’ fastadhÌre 3
  • Tampa General Hospital, Tampa
  • Saint Joseph's Hospital/Children's Hospital-Tampa, Tampa
6 Months – 21 Years · Gach gnè · Air ùrachadh 17 Sult 2026 · NCT04293562

A Study of BGB-11417 in Participants With Myeloid Malignancies

A’ fastadhÌre 1/2
  • Tampa General Hospital, Tampa
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 14 Sult 2026 · NCT04771130

A Phase Ib Study of Rezatapopt in Combination With Azacitidine in Patients With TP53Y220C Mutant Myeloid Malignancies (Acute Myeloid Leukemia or Myelodysplastic Syndrome)

A’ fastadhÌre 1
  • Moffitt Cancer Center, Tampa
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 11 Sult 2026 · NCT06616636

A Study to Assess the Safety, Tolerability, and Antileukemic Activity of Debio 1562M in Participants With Acute Myeloid Leukemia (AML)

A’ fastadhÌre 1/2
  • Moffitt Cancer Center and Research Institute Hospital, Tampa
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 11 Sult 2026 · NCT06969430

Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML

A’ fastadhÌre 1/2
  • Moffitt Cancer Center, Tampa
Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 3 Sult 2026 · NCT04588922

Eganelisib as Monotherapy and in Combination With Cytarabine in Relapsed/Refractory AML

A’ fastadhÌre 1
  • Moffitt Cancer Center, Tampa
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Lùna 2026 · NCT06533761

Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)

A’ fastadhÌre 3
  • Saint Joseph's Hospital - Tampa, Tampa
29 Days – 21 Years · Gach gnè · Air ùrachadh 24 Lùna 2026 · NCT05183035

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

A’ fastadhÌre 3
  • Moffitt Cancer Center & Research Institute, Tampa
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 20 Lùna 2026 · NCT07007312

ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies

A’ fastadhÌre 1
  • H Lee Moffitt Cancer Center & Research Institute, Tampa
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 18 Lùna 2026 · NCT06656494

Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT

A’ fastadhÌre 3
  • Moffitt Cancer Center, Tampa
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 17 Iuch 2026 · NCT05429632

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

A’ fastadhÌre 2
  • Moffitt Cancer Center, Tampa
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 7 Iuch 2026 · NCT07216443

BCL2i CLAG-M in R/R Acute Myeloid Leukemia

A’ fastadhÌre 2
  • Moffitt Cancer Center, Tampa
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 1 Gibl 2026 · NCT06660368

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

A’ fastadhÌre 1/2
  • Moffitt Cancer Center, Tampa
Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 24 Màrt 2026 · NCT04988555

A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias

A’ fastadhÌre 1
  • Moffitt Cancer Center, Tampa
Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 16 Màrt 2026 · NCT06994676

Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)

A’ fastadhÌre 2
  • Moffitt Cancer Center, Tampa
Aoisean 1 gu 60 · Gach gnè · Air ùrachadh 12 Màrt 2026 · NCT03970096

Discontinuation of Hypomethylating Agent and Venetoclax in Patients With AML MRD

A’ fastadhÌre 2
  • Moffitt Cancer Center, Tampa
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 27 Gearr 2026 · NCT06511882

CPX-351 in Combination With Gemtuzumab Ozogamicin in Newly Diagnosed AML

A’ fastadhÌre 1
  • Moffitt Cancer Center, Tampa
Aoisean 18 gu 70 · Gach gnè · Air ùrachadh 27 Gearr 2026 · NCT05558124

A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML)

A’ fastadhÌre 1
  • Moffitt, Tampa
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 9 Gearr 2026 · NCT06950034

CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)

A’ fastadhÌre 1
  • Moffitt Cancer Center, Tampa
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 16 Faoi 2026 · NCT05143996

Safety of MT-401-OTS in Patients With Relapsed AML or MDS

A’ fastadhÌre 1
  • Moffitt Cancer Center, Tampa
Aoisean 65 agus nas sine · Gach gnè · Air ùrachadh 16 Dùbh 2025 · NCT06552416

A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome

A’ fastadhÌre 1
  • Moffitt Cancer Center, Tampa
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 24 Sult 2025 · NCT06501196

Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia

A’ fastadhFàilte do shaor-thoilich fhallain
  • Moffitt Cancer Center, Tampa
Aoisean 18 gu 120 · Gach gnè · Air ùrachadh 25 Iuch 2025 · NCT05237258

Study of REM-422 in Patients With AML or Higher Risk MDS

A’ fastadhÌre 1
  • Moffitt Cancer Center, Tampa
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 23 Gibl 2025 · NCT06297941

Sgrùdaidhean Leukemia myeloid geur ann am bailtean eile

Sgrùdaidhean eile ann an Tampa

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.